Patent · US Active

Benzende sulfonamide derivatives as HIV integrase inhibitors

US10301258B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 26, 2015
Grant dateMay 28, 2019
Priority date—
Expiry dateFeb 26, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C311/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating retroviral infection or inhibiting HIV integrase in target cells or in a patient involve administering to target cells or to a patient in need of treatment an effective amount of at least one having a disulfonamide scaffold which is represented by the formula: wherein, independent of each other,

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.